Metagenomics Market Research Report – Recent Trends, Growth Opportunities, and Market Size and Share Global Forecast Analysis – 2024 - 2033

Metagenomics Market Size Research Report – In a Glance

As per the Research report on global Metagenomics market, the market is projected to foresee a CAGR of CAGR value 14.2% between 2024-2033, and further generate a market size of USD 7.3 billion revenue by the end of 2033. In the year 2024, the market size was valued at USD 2.2 billion revenue.

• The global Metagenomics market is projected to grow on account of the surge in prevalence of infectious diseases.
• In Japan, the Metagenomics market growth can be attributed to the increasing healthcare and clinical research.
• KDMI analyst’s growth analysis foresees limited availability of data to challenge the market growth.
• North America, having the highest market share in the Metagenomics market, is projected to dominate the global market.

Metagenomics Market Analysis

In a nutshell, metagenomics is the study of metagenome, the complete set of genomic content from all microbes residing in environment. It is also known as environmental genomics or ecogenomics because it involves the analysis of genetic material obtained directly from environmental sources without relying on the traditional process of microbial culture. Metagenomics is reshaping today’s medical world with the help of direct pathogen analysis, microbial profiling and antimicrobial resistance detection. Nowadays, the escalating number of infectious disease cases has become a significant concern for humans that calls for quick and accurate microbial detection for its diagnosis and treatment. Also, the World Health Organization (WHO) assumed that near about 13 million deaths will be prey to infectious diseases by 2050. Hence, the increasing reliance on metagenomics for clinical diagnosis is accelerating the market growth by increasing the adoption of cutting-edge sequencing methods, bioinformatics software and molecular testing kits.

Thermo Fisher Scientific Inc., Illumina Inc., QIAGEN, are some of the significant parties in the global market for Metagenomics.

Analyst’s Observation on Japan Metagenomics Market Research

In Japan, the market growth for Metagenomics can be associated with the extensive healthcare and clinical research. Due to excellent technological progress, growing geriatric care needs, and strong government backing, Japan’s medical sector is seeing new heights. Moreover, Japan is pioneering in the field of genomics and proteomics. As per reports, the country has recently finished complete genomic sequencing for 69,000 Japanese people in 2023 which ranks among the largest genomic analyses of the world’s general population. Therefore, the increasing funding in biotechnology, personalized medicines and genomic research is resulting in advanced medical innovations and enhanced healthcare outcomes which are eventually driving the metagenomics market in the country. 

Metagenomics Market Growth Drivers and Challenges

Growth Drivers

• Automation in sequence technology:

The integration of automation in sequencing is revolutionizing the metagenomics field because of the growing need for enhanced efficiency, precision, and scalability of genomic research in recent times. Automation optimizes the sequencing process in multiple ways involving sample processing, nucleic acid extraction, library generation, and data interpretation. Besides, automation improves accuracy by lowering dependence on human input. A3, the Association for Advancing Automation, is the largest automation trade association in North America accounting for over 1,250 organizations involved in machine vision & imaging, motion control & motors, robotics, artificial intelligence, and related automation technologies. Examining diverse microbial communities requires large datasets with high accuracy and as automation keeps advancing, it helps scientists to carry out research with greater precision, creating the demand for metagenomics and ultimately driving the market.

• Government initiatives supporting genomic sequencing projects:

The expanding government actions and support are boosting the large-scale genomic sequencing projects through funding, developing infrastructure and fostering collaborations between governments, research institutions, and business players. These initiatives further improve data availability, and drive technological advancements, thereby supporting the overall metagenomics market expansion and scientific development. Recently, India took a remarkable step forward in genomics by creating its own genomic database. In fact, it is a groundbreaking success that will promote upcoming discoveries in medicine and science. The 'GenomeIndia' project, funded by the Department of Biotechnology (DBT) aims to create a strong and extensive database of the genetic diversity of the country which will lay the foundation of future advanced research.

Restraints

• Limited availability of data:

One of the significant constraints of metagenomics is the insufficient data or scarce information available for research purposes. This may pose challenges for researchers to identify and collect information about undiscovered microbes on the first test, producing erroneous or less reliable results. In addition, many research institutions do not have the tools or proficiency to conduct microbial tests, contributing to even more data constraints, thereby, reducing the market potential further.

• Lack of standardization in data management and analytical tools:

The lack of standard protocols for data management and analytical tools creates a key hurdle across industries. The absence of proper guidelines results in difficulties comparing findings across studies, errors, and delayed progress, restricting the growth of research sector. Therefore, as the progress is hindered, the adoption of metagenomics technologies is also hampered, eventually affecting the global market evolution.

Metagenomics Market Segmentation

Our experts at KD Market Insights have segmented the global Metagenomics market research report as : 

Metagenomics Market Regional Synopsis

The North America is likely to command the Metagenomics market which is majorly driven by the presence of leading biotechnological companies, increasing prevalence of chronic diseases, and better adoption of advanced diagnostic techniques. In addition to that, the increasing investment in R&D activities in the region is also helping the market to grow further. According to 2021 reports, the U.S. continues to be the highest spender, funding 32% of global in research and development. Furthermore, partnerships foster advancements in the field of medicine, biotechnology and life sciences, pushing the regional market forward.

Asia-Pacific records the quickest expansion in the metagenomics market due to various factors such as increasing healthcare expenditure, rising R&D investment, growing geriatric population and swift economic progress. China is leading across the region excluding the Japan portion during the given timeframe. The country is experiencing such growth due to its higher incidence of infectious diseases, heightened investments in genetic research and rising demand for genetic sequencing. Furthermore, Japan is experiencing a fast growth due to the presence of endangered species like Asian leopard cat, brown-spotted cat shark, and Blakiston’s fish owl. This is because metagenomics contribute substantially to their conservation which is leading to the growth of the overall metagenomics market in the region.

As per our analysts at KD Market Insights, the following five players lead the North America Metagenomics market growth:

• Oxford Nanopore Technologies
• QIAGEN
• Illumina, Inc.
• Pacific Biosciences of California, Inc.
• Swift Biosciences Inc.

Metagenomics Market Competitive Landscape

Some of the key players who top the global Metagenomics market share:

• ENTEROME
• IntegraGen
• Oxford Nanopore Technologies
• QIAGEN
• Illumina, Inc.
• Pacific Biosciences of California, Inc.
• Swift Biosciences Inc.
• Thermo Fisher Scientific Inc.
• BGI
• Bio-Rad Laboratories, Inc.
• Promega Corporation.
• Others

1. Executive Summary
   1. Market Overview
   2. Key Findings
   3. Market Trends
   4. Market Outlook
2. Introduction
   1. Scope of the Report
   2. Research Methodology
   3. Definitions and Assumptions
   4. Acronyms and Abbreviations
3. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
   4. Challenges
4. Global Metagenomics Market
   1. Market Overview
   2. Market Size and Forecast
   3. Market Segmentation
      1. By Product type
      2. By Technology
      3. By Application
      4. By End-user
      5. By Region
5. Market Segmentation by Product type
   1. 1. Instruments
      2. Kits and reagents
      3. Software and services
      4. Others
6. Market Segmentation by Technology
   1. 1. 16s sequencing
      2. Whole genome sequencing
      3. Shotgun sequencing
      4. Others
7. Market Segmentation by Application
   1. 1. Ecology and environment
      2. Clinical diagnostics
      3. Drug delivery
      4. Biotechnology
      5. Food and beverages
      6. Others
8. Market Segmentation by End-user
   1. 1. Pharmaceutical industries
      2. Research laboratories
      3. Biotechnology companies
      4. Pathology laboratories
      5. Academic and research institutes
      6. Others
9. Regional Analysis
   1. North America
      1. United States
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
      2. Canada
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
      3. Mexico
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
   2. Europe
      1. United Kingdom
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
      2. Germany
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
      3. France
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
      4. Italy
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
      5. Spain
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
      6. Rest of Europe
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
   3. Asia Pacific
      1. China
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
      2. Japan
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
      3. India
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
      4. Australia
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
         4. South Korea
         5. Market Size and Forecast
         6. Key Trends and Developments
         7. Market Analysis by Product type, Technology, Application and End-user
      5. Rest of Asia Pacific
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
   4. Latin America
      1. Brazil
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
      2. Argentina
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
      3. Colombia
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
      4. Rest of Latin America
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
   5. Middle East & Africa
      1. South Africa
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
      2. Saudi Arabia
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
      3. UAE
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, Application and End-user
      4. Rest of Middle East & Africa
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Product type, Technology, and Application
10. Competitive Landscape
    1. Market Share Analysis
    2. Company Profiles
       1. ENTEROME
       2. IntegraGen
       3. Oxford Nanopore Technologies
       4. QIAGEN
       5. Illumina, Inc.
       6. Pacific Biosciences of California, Inc.
       7. Swift Biosciences Inc.
       8. Thermo Fisher Scientific Inc.
       9. BGI
       10. Bio-Rad Laboratories, Inc.
       11. Promega Corporation.
       12. Others
11. Strategic Recommendations
12. Appendix
    1. List of Tables
    2. List of Figures
13. References